In chronic myelogenous leukemia (CML), overexpression of tyrosine-protein kinase, Lyn, has been shown to reduce miR-181 expression, which directly targets MCL1 [118]. The gene discussed is LYN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.